Here, we review those strategies targeting IDH2, CD39, nicotinamide phosphoribosyl transferase (NAMPT) and OXPHOS are putative avenues to regulate the intrinsic mitochondrial-mediated cellular processes hijacked by AML cells (Figure 2). The gene discussed is IDH2; the disease is acute myeloid leukemia.